Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0000950170-24-056083

Options or other derivatives

  • Chief Medical Officer acquired 25,380 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Macdonald R. Loch Chief Medical Officer 2024-05-06 Grant or award · Stock Options (Right to Buy) +25,380 25,380 D
Loading xslF345X05/ownership.xml…